Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
Hims & Hers to Offer Treatments for Menopause, Perimenopause
08:55am, Wednesday, 15'th Oct 2025
Hims & Hers Health said it is now providing menopause care, marking the company's latest push into hormone-replacement therapies.
Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell?
02:16pm, Tuesday, 14'th Oct 2025
HIMS expands into men's health and hormones, but rising costs and regulatory hurdles threaten its momentum.
Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025
04:05pm, Monday, 13'th Oct 2025
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2025 financial res
Hims & Hers: Why I'm Betting On HIMS Heading To $100
12:16pm, Monday, 13'th Oct 2025
I see a clear path for Hims & Hers Health to reach $100 a share, and I plan to be there when it gets there. HIMS expects revenue growth to rebound, driven by weight loss and new health offerings, aimi
Taking Advantage Of Hims & Hers Stock Volatility
01:59pm, Friday, 10'th Oct 2025
This options trade set up a potential buying of volatile Hims & Hers Health stock at a discount.
Hims & Hers Expands Personalized Care Access Via Telehealth Platform
02:56pm, Thursday, 09'th Oct 2025
HIMS expands its AI-powered telehealth platform, boosting personalized care and eyeing international growth in 2026.
How Hims & Hers founder Joe Spector turned 10 failures into $1B idea
02:20pm, Thursday, 09'th Oct 2025
Listen and subscribe to The Big Idea with Elizabeth Gore on Apple Podcasts, Spotify, or wherever you find your favorite podcast. How do you break into a tough market and win?
Customers Say Care Through Hims & Hers Matches, or Beats, the Doctor's Office
09:00am, Thursday, 09'th Oct 2025
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) today published a new white paper - Understanding Hims & Hers Approach to Clinical Excellence, Quality, and Safety - detailing how
Hims & Hers Looks To Close $10 ARPU Gap With Product Expansion And Partnerships
08:15am, Wednesday, 08'th Oct 2025
Hims & Hers is driving growth through holistic treatment plans, strategic pharma partnerships, and expanded prescription offerings to boost revenue per subscriber. HIMS' recent partnership with Marius
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
10:02am, Tuesday, 07'th Oct 2025
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Hims & Hers Stock Slipped Today
06:27pm, Friday, 03'rd Oct 2025
The market often gets worried when a company announces a major change in its C-suite. On news that it was doing just that, on Friday the stock of consumer healthcare company Hims & Hers (HIMS -9.05%)
Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties
11:37am, Friday, 03'rd Oct 2025
PHILADELPHIA , Oct. 3, 2025 /PRNewswire/ -- Berger Montague , a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS)
Hims & Hers Expands Health Access Through Subscription Revenue Model
11:01am, Friday, 03'rd Oct 2025
HIMS boosts predictable revenue and customer loyalty with a flexible, subscription-based model across key health categories.
OMCL or HIMS: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 01'st Oct 2025
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the be
Buy HIMS Stock At $56?
06:35am, Wednesday, 01'st Oct 2025
Hims & Hers stock (NASDAQ: HIMS) has recently witnessed a remarkable rebound, climbing 42% over the last month from approximately $42 to its current price of $59. This significant increase is primaril
